CD40 and neoplasm: A lower death risk in negative CD40 mutant cases was observed comparing with positive CD40 mutant cases after sex, age, depth of tumor invasion, and lymph node metastasis were adjusted (HR = 0.383, 95% CI 0.227-0.646, P <0.001).